Showing results (21-30 of 185) with videos related to
Sort By:
Pageof 19
Journal of Viral Hepatitis|September 29, 2021
Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaignTommaso Stroffolini, Filomena Morisco, Luigina Ferrigno, et al.European Journal of Internal Medicine|October 27, 2018
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveysTommaso Stroffolini, Evangelista Sagnelli, Caterina Sagnelli, et al.Free Radical Research|September 7, 2004
Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assayFilomena Morisco, Veronica Verde, Vincenzo Fogliano, et al.Journal of Medical Virology|March 25, 2015
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practiceMaria Guarino, Tommaso Stroffolini, Flavia Lucia Lombardo, et al.Therapeutics and Clinical Risk Management|July 26, 2014
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.Targeted Oncology|August 10, 2016
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular CarcinomaGiovan Giuseppe Di Costanzo, Raffaella Tortora, Filomena Morisco, et al.Journal of Medical Virology|July 20, 2016
Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decadesFilomena Morisco, Ilaria Loperto, Tommaso Stroffolini, et al.World Journal of Gastroenterology|April 8, 2014
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel diseaseStefano Sansone, Maria Guarino, Fabiana Castiglione, et al.Journal of Clinical Gastroenterology|June 29, 2004
Tomato-based functional food as interferon adjuvant in HCV eradication therapyFilomena Morisco, Paola Vitaglione, Antonella Carbone, et al.European Journal of Endocrinology|June 1, 2002
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidismCarlo Carella, Gherardo Mazziotti, Filomena Morisco, et al.Pageof 19